This report provides descriptive, unweighted data that can be used to describe HIV infection among MSM and the percentages reporting specific risk behaviors, HIV testing, and participation in prevention programs.
Prescribe HIV Prevention is part of CDC’s Act Against AIDS communication campaign designed to help reduce HIV incidence in the United States. The Prescribe HIV Prevention program helps healthcare providers use PrEP and PEP to prevent new HIV infections and improve health outcomes for patients at high risk for acquiring HIV infection.
This information sheet highlights syphilis and HIV screening practices for pregnant women. The Centers for Disease Control and Prevention (CDC) recommends prenatal testing for syphilis and HIV during a woman’s first prenatal visit and repeat testing for “high-risk” mothers during the third trimester (preferably 28-32 weeks).